NO991619L - Anvendelse av en H+, K+-ATPase-inhibitor i behandlingen av nesepolypper - Google Patents

Anvendelse av en H+, K+-ATPase-inhibitor i behandlingen av nesepolypper

Info

Publication number: NO991619L
Authority: NO; Norway
Prior art keywords: treatment; nasal polyps; atpase inhibitor; atpase; inhibitor
Prior art date: 1996-10-11

Application number

NO991619A

Other languages

English (en)

Other versions

NO991619D0 (no

NO321007B1 (no

Inventor

Per Lindberg

Joan Pinas-Masso

Jordi Serra-Carreras

Jan Trofast

Original Assignee

Astra Ab

Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)

1996-10-11

Filing date

1999-04-06

Publication date

1999-04-06

1999-04-06 Application filed by Astra Ab filed Critical Astra Ab

1999-04-06 Publication of NO991619L publication Critical patent/NO991619L/no

1999-04-06 Publication of NO991619D0 publication Critical patent/NO991619D0/no

2006-02-27 Publication of NO321007B1 publication Critical patent/NO321007B1/no

Classifications

- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
- A61K31/44—Non condensed pyridines; Hydrogenated derivatives thereof
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/41—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
- A61K31/4164—1,3-Diazoles
- A61K31/4184—1,3-Diazoles condensed with carbocyclic rings, e.g. benzimidazoles
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
- A61K31/44—Non condensed pyridines; Hydrogenated derivatives thereof
- A61K31/4427—Non condensed pyridines; Hydrogenated derivatives thereof containing further heterocyclic ring systems
- A61K31/4439—Non condensed pyridines; Hydrogenated derivatives thereof containing further heterocyclic ring systems containing a five-membered ring with nitrogen as a ring hetero atom, e.g. omeprazole
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
- A61K31/44—Non condensed pyridines; Hydrogenated derivatives thereof
- A61K31/4427—Non condensed pyridines; Hydrogenated derivatives thereof containing further heterocyclic ring systems
- A61K31/444—Non condensed pyridines; Hydrogenated derivatives thereof containing further heterocyclic ring systems containing a six-membered ring with nitrogen as a ring heteroatom, e.g. amrinone
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/56—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids
- A61K31/57—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids substituted in position 17 beta by a chain of two carbon atoms, e.g. pregnane or progesterone
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P11/00—Drugs for disorders of the respiratory system
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P11/00—Drugs for disorders of the respiratory system
- A61P11/02—Nasal agents, e.g. decongestants
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P11/00—Drugs for disorders of the respiratory system
- A61P11/06—Antiasthmatics
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P27/00—Drugs for disorders of the senses
- A61P27/16—Otologicals
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]

Landscapes

Health & Medical Sciences (AREA)
General Health & Medical Sciences (AREA)
Life Sciences & Earth Sciences (AREA)
Chemical & Material Sciences (AREA)
Public Health (AREA)
Veterinary Medicine (AREA)
Medicinal Chemistry (AREA)
Animal Behavior & Ethology (AREA)
Pharmacology & Pharmacy (AREA)
Epidemiology (AREA)
Organic Chemistry (AREA)
Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
General Chemical & Material Sciences (AREA)
Chemical Kinetics & Catalysis (AREA)
Engineering & Computer Science (AREA)
Bioinformatics & Cheminformatics (AREA)
Pulmonology (AREA)
Pain & Pain Management (AREA)
Rheumatology (AREA)
Otolaryngology (AREA)
Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Medicinal Preparation (AREA)
Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
Nitrogen Condensed Heterocyclic Rings (AREA)
Plural Heterocyclic Compounds (AREA)
Steroid Compounds (AREA)

NO19991619A 1996-10-11 1999-04-06 Anvendelse av en H+,KC-ATPase-inhibitor og et glukokortikoid ved behandlingen av Widals syndrom og nesepolypper, samt en farmasoytisk formulering som innbefatter en H+,K+-ATPase-inhibitor og et glukokortikoid NO321007B1 (no)

Applications Claiming Priority (2)

Application Number	Priority Date	Filing Date	Title
SE9603725A SE9603725D0 (sv)	1996-10-11	1996-10-11	New teatment
PCT/SE1997/001651 WO1998016228A1 (en)	1996-10-11	1997-10-01	USE OF AN H+, K+-ATPase INHIBITOR IN THE TREATMENT OF NASAL POLYPS

Publications (3)

Publication Number	Publication Date
NO991619L true NO991619L (no)	1999-04-06
NO991619D0 NO991619D0 (no)	1999-04-06
NO321007B1 NO321007B1 (no)	2006-02-27

Family

ID=20404214

Family Applications (1)

Application Number	Title	Priority Date	Filing Date
NO19991619A NO321007B1 (no)	1996-10-11	1999-04-06	Anvendelse av en H+,KC-ATPase-inhibitor og et glukokortikoid ved behandlingen av Widals syndrom og nesepolypper, samt en farmasoytisk formulering som innbefatter en H+,K+-ATPase-inhibitor og et glukokortikoid

Country Status (33)

Country	Link
EP (1)	EP0946175B1 (no)
JP (1)	JP4100713B2 (no)
KR (1)	KR100510812B1 (no)
CN (1)	CN1146416C (no)
AR (1)	AR008886A1 (no)
AT (1)	ATE230597T1 (no)
AU (1)	AU738310B2 (no)
BR (1)	BR9711896A (no)
CA (1)	CA2268305C (no)
CZ (1)	CZ298799B6 (no)
DE (1)	DE69718347T2 (no)
DK (1)	DK0946175T3 (no)
EE (1)	EE04043B1 (no)
ES (1)	ES2188995T3 (no)
HU (1)	HUP0000036A3 (no)
ID (1)	ID23692A (no)
IL (1)	IL129324A0 (no)
IS (1)	IS1930B (no)
MY (1)	MY117918A (no)
NO (1)	NO321007B1 (no)
NZ (1)	NZ334786A (no)
PL (1)	PL190902B1 (no)
PT (1)	PT946175E (no)
RS (1)	RS49599B (no)
RU (1)	RU2197966C2 (no)
SA (1)	SA97180641B1 (no)
SE (1)	SE9603725D0 (no)
SK (1)	SK284252B6 (no)
TR (1)	TR199900770T2 (no)
TW (1)	TW568784B (no)
UA (1)	UA59374C2 (no)
WO (1)	WO1998016228A1 (no)
ZA (1)	ZA978842B (no)

Families Citing this family (18)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
US6489346B1 (en)	1996-01-04	2002-12-03	The Curators Of The University Of Missouri	Substituted benzimidazole dosage forms and method of using same
US5840737A (en)	1996-01-04	1998-11-24	The Curators Of The University Of Missouri	Omeprazole solution and method for using same
HRP20010119B1 (hr)	1998-08-18	2008-05-31	The Regents Of The University Of California	Sprječavanje stvaranja sluzi u dišnim putevima primjenom antagonista egf-r
US6846799B1 (en) *	1998-08-18	2005-01-25	The Regents Of The University Of California	Preventing airway mucus production by administration of EGF-R antagonists
US7354894B2 (en)	1998-08-18	2008-04-08	The Regents Of The University Of California	Preventing airway mucus production by administration of EGF-R antagonists
PL206121B1 (pl) *	1999-03-03	2010-07-30	Optinose Asoptinose As	Nosowe urządzenie do dostarczania substancji do nosowej części dróg oddechowych pacjenta
US20050020637A1 (en) *	2001-11-19	2005-01-27	Wolfgang-Alexander Simon	Agents for the treatment of airway disorders
AU2003218726A1 (en) *	2002-03-14	2003-09-22	Altana Pharma Ag	Use of proton pump inhibitors for the treatment of airway disorders
RS95304A (sr) *	2002-05-07	2006-12-15	Altana Pharma Ag.	Nova kombinacija za tretman oboljenja disajnih puteva
JP2005526848A (ja) *	2002-05-07	2005-09-08	アルタナ　ファルマ　アクチエンゲゼルシャフト	気道疾患を治療するための組み合わせ
FR2845915B1 (fr) *	2002-10-21	2006-06-23	Negma Gild	Utilisation du tenatoprazole pour le traitement du reflux gastro-oesophagien
RS51707B (sr)	2002-12-12	2011-10-31	Nycomed Gmbh.	Kombinacija leka sastavljena od r, r - formoterola i ciklezonida
US8993599B2 (en)	2003-07-18	2015-03-31	Santarus, Inc.	Pharmaceutical formulations useful for inhibiting acid secretion and methods for making and using them
DK1670482T4 (da)	2003-09-16	2022-08-22	Covis Pharma B V	Anvendelse af ciclesonid til behandlingen af respiratoriske sygdomme
RU2252025C1 (ru) *	2003-11-28	2005-05-20	Дальневосточный государственный медицинский университет	Способ лечения избыточной грануляционной ткани гортани и трахеи
US8906940B2 (en)	2004-05-25	2014-12-09	Santarus, Inc.	Pharmaceutical formulations useful for inhibiting acid secretion and methods for making and using them
CN104408249B (zh) *	2014-11-24	2017-09-26	广州供电局有限公司	单芯电缆导体热性参数的确定方法及系统
KR101974504B1 (ko) *	2017-04-10	2019-05-03	재단법인 아산사회복지재단	호산구성 비용종 동물모델

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
GB1429184A (en) *	1972-04-20	1976-03-24	Allen & Hanburys Ltd	Physically anti-inflammatory steroids for use in aerosols
GB1571629A (en) *	1977-11-30	1980-07-16	Fisons Ltd	Pharmaceutical compositions containing beclomethasone dipropionate

1996
- 1996-10-11 SE SE9603725A patent/SE9603725D0/xx unknown
1997
- 1997-01-10 UA UA99042004A patent/UA59374C2/uk unknown
- 1997-10-01 ID IDW990139D patent/ID23692A/id unknown
- 1997-10-01 HU HU0000036A patent/HUP0000036A3/hu unknown
- 1997-10-01 AU AU46409/97A patent/AU738310B2/en not_active Ceased
- 1997-10-01 SK SK384-99A patent/SK284252B6/sk unknown
- 1997-10-01 PL PL332692A patent/PL190902B1/pl not_active IP Right Cessation
- 1997-10-01 NZ NZ334786A patent/NZ334786A/xx unknown
- 1997-10-01 DK DK97945135T patent/DK0946175T3/da active
- 1997-10-01 DE DE69718347T patent/DE69718347T2/de not_active Expired - Fee Related
- 1997-10-01 JP JP51824698A patent/JP4100713B2/ja not_active Expired - Fee Related
- 1997-10-01 AT AT97945135T patent/ATE230597T1/de not_active IP Right Cessation
- 1997-10-01 CA CA002268305A patent/CA2268305C/en not_active Expired - Fee Related
- 1997-10-01 CN CNB971985847A patent/CN1146416C/zh not_active Expired - Fee Related
- 1997-10-01 RS YUP-163/99A patent/RS49599B/sr unknown
- 1997-10-01 RU RU99109596/14A patent/RU2197966C2/ru not_active IP Right Cessation
- 1997-10-01 ES ES97945135T patent/ES2188995T3/es not_active Expired - Lifetime
- 1997-10-01 CZ CZ0122999A patent/CZ298799B6/cs not_active IP Right Cessation
- 1997-10-01 BR BR9711896A patent/BR9711896A/pt not_active Application Discontinuation
- 1997-10-01 PT PT97945135T patent/PT946175E/pt unknown
- 1997-10-01 IL IL12932497A patent/IL129324A0/xx not_active IP Right Cessation
- 1997-10-01 WO PCT/SE1997/001651 patent/WO1998016228A1/en not_active Ceased
- 1997-10-01 EP EP97945135A patent/EP0946175B1/en not_active Expired - Lifetime
- 1997-10-01 EE EEP199900118A patent/EE04043B1/xx not_active IP Right Cessation
- 1997-10-01 KR KR10-1999-7003115A patent/KR100510812B1/ko not_active Expired - Fee Related
- 1997-10-01 TR TR1999/00770T patent/TR199900770T2/xx unknown
- 1997-10-02 ZA ZA9708842A patent/ZA978842B/xx unknown
- 1997-10-07 MY MYPI97004697A patent/MY117918A/en unknown
- 1997-10-07 TW TW086114622A patent/TW568784B/zh not_active IP Right Cessation
- 1997-10-08 AR ARP970104655A patent/AR008886A1/es unknown
- 1997-11-23 SA SA97180641A patent/SA97180641B1/ar unknown
1999
- 1999-04-06 NO NO19991619A patent/NO321007B1/no unknown
- 1999-04-08 IS IS5021A patent/IS1930B/is unknown

Also Published As

Publication number	Publication date
RU2197966C2 (ru)	2003-02-10
IS5021A (is)	1999-04-08
JP2001508034A (ja)	2001-06-19
CA2268305A1 (en)	1998-04-23
ZA978842B (en)	1998-04-14
IL129324A0 (en)	2000-02-17
HK1022848A1 (en)	2000-08-25
TW568784B (en)	2004-01-01
SK284252B6 (sk)	2004-12-01
EE04043B1 (et)	2003-06-16
RS49599B (sr)	2007-06-04
HU0000036D0 (no)	2002-05-29
DE69718347D1 (de)	2003-02-13
UA59374C2 (uk)	2003-09-15
CZ122999A3 (cs)	1999-09-15
CA2268305C (en)	2006-11-28
IS1930B (is)	2004-05-18
CZ298799B6 (cs)	2008-02-06
PL332692A1 (en)	1999-09-27
KR20000049046A (ko)	2000-07-25
MY117918A (en)	2004-08-30
DE69718347T2 (de)	2003-08-28
KR100510812B1 (ko)	2005-08-31
PL190902B1 (pl)	2006-02-28
SK38499A3 (en)	2000-03-13
HUP0000036A3 (en)	2003-02-28
JP4100713B2 (ja)	2008-06-11
EP0946175A1 (en)	1999-10-06
CN1232397A (zh)	1999-10-20
NO991619D0 (no)	1999-04-06
WO1998016228A1 (en)	1998-04-23
CN1146416C (zh)	2004-04-21
EP0946175B1 (en)	2003-01-08
PT946175E (pt)	2003-04-30
HUP0000036A2 (hu)	2002-05-29
NO321007B1 (no)	2006-02-27
TR199900770T2 (xx)	1999-06-21
NZ334786A (en)	2000-12-22
AR008886A1 (es)	2000-02-23
SA97180641B1 (ar)	2005-12-18
EE9900118A (et)	1999-10-15
YU16399A (sh)	2000-03-21
ID23692A (id)	2000-05-11
DK0946175T3 (da)	2003-03-17
ES2188995T3 (es)	2003-07-01
ATE230597T1 (de)	2003-01-15
SE9603725D0 (sv)	1996-10-11
AU738310B2 (en)	2001-09-13
AU4640997A (en)	1998-05-11
BR9711896A (pt)	1999-08-24

Publication	Publication Date	Title
NO991619D0 (no)	1999-04-06	Anvendelse av en H+, K+-ATPase-inhibitor i behandlingen av nesepolypper
DE69719108D1 (de)	2003-03-27	Plasmabehandlungsgerät
KR960012312A (ko)	1996-04-20	플라즈마처리장치
ATE371457T1 (de)	2007-09-15	Verwendung von antimykotica zur topischen behandlung von pilz-induzierten schleimhautentzündungen
NO983266D0 (no)	1998-07-15	Distribuert Behandling
NO991381D0 (no)	1999-03-22	Kombinasjonsterapi for behandling av psykoser
NO20014379L (no)	2001-11-07	Anvendelse av Xenon for behandling av Neurointoksikasjoner
DE122009000012I1 (de)	2011-12-01	Substituierte pyrazolyl-benzolsulfonamide zur behandlung von entzundungen.
DE69925306D1 (de)	2005-06-16	Behandlung von kohlenwasserstoffgas
EE200100370A (et)	2002-10-15	Teraapias kasutatavad spirofuropüridiinide uued aralküülamiinid
FI973292A7 (fi)	1997-10-10	Substituoituja isoksatsoleja tulehduksen hoitamiseksi
DE60041641D1 (de)	2009-04-09	Plasma behandlungsapparat
NO991459L (no)	1999-03-25	Anvendelse av 1-hydroksy-2-pyridoner til behandling av hudinfeksjoner
DE69718808D1 (de)	2003-03-06	Plasmabehandlungsmethode
NO983263D0 (no)	1998-07-15	Distribuert behandling
NO20013337D0 (no)	2001-07-05	Ny behandling
NO20012541D0 (no)	2001-05-23	Anvendelse av fosfonomaursyrederivater for behandling av infeksjoner
DE60037935D1 (de)	2008-03-20	Kontinuierliches behandlungssystem
FI964809A0 (fi)	1996-12-02	En utrustning foer tillverkning av taeckplaot
NO20004920D0 (no)	2000-09-29	Anvendelse av proteaseinhibitorer for behandling av hudskader
NO20003529D0 (no)	2000-07-07	Behandling av dyskinesi
NO20010569D0 (no)	2001-02-02	Proteaseinhibitorer for anvendelse ved behandling av psoriasis
NO20002481D0 (no)	2000-05-12	Kombinasjonsterapi for behandling av AIDS
DE69737088D1 (de)	2007-01-25	Therapeutisches agens zur behandlung von fiv infektionen
NO20013464D0 (no)	2001-07-12	Anvendelse av 3-isoksazolidinoner og hydroksylaminsyrer for behandling av infeksjoner